Gladstone Institutional Advisory LLC Journey Medical Corp Transaction History
Gladstone Institutional Advisory LLC
- $2 Billion
- Q3 2024
A detailed history of Gladstone Institutional Advisory LLC transactions in Journey Medical Corp stock. As of the latest transaction made, Gladstone Institutional Advisory LLC holds 33,481 shares of DERM stock, worth $127,227. This represents 0.01% of its overall portfolio holdings.
Number of Shares
33,481
Previous 33,481
-0.0%
Holding current value
$127,227
Previous $188,000
0.53%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding DERM
# of Institutions
39Shares Held
2.93MCall Options Held
0Put Options Held
0-
B. Riley Securities, Inc. Los Angeles, CA865KShares$3.29 Million0.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA325KShares$1.24 Million0.0% of portfolio
-
Cambridge Investment Research Advisors, Inc.314KShares$1.19 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny268KShares$1.02 Million0.0% of portfolio
-
American Financial Group Inc180KShares$684,0000.44% of portfolio
About Journey Medical Corp
- Ticker DERM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 11,596,500
- Market Cap $44.1M
- Description
- Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat...